Royo-García Alba, Courtois Sarah, Parejo-Alonso Beatriz, Espiau-Romera Pilar, Sancho Patricia
Hospital Universitario Miguel Servet, IIS Aragón, Zaragoza 50009, Spain.
World J Stem Cells. 2021 Sep 26;13(9):1307-1317. doi: 10.4252/wjsc.v13.i9.1307.
Previously regarded as simple fat storage particles, new evidence suggests that lipid droplets (LDs) are dynamic and functional organelles involved in key cellular processes such as membrane biosynthesis, lipid metabolism, cell signalling and inflammation. Indeed, an increased LD content is one of the most apparent features resulting from lipid metabolism reprogramming necessary to support the basic functions of cancer cells. LDs have been associated to different cellular processes involved in cancer progression and aggressiveness, such as tumorigenicity, invasion and metastasis, as well as chemoresistance. Interestingly, all of these processes are controlled by a subpopulation of highly aggressive tumoral cells named cancer stem cells (CSCs), suggesting that LDs may be fundamental elements for stemness in cancer. Considering the key role of CSCs on chemoresistance and disease relapse, main factors of therapy failure, the design of novel therapeutic approaches targeting these cells may be the only chance for long-term survival in cancer patients. In this sense, their biology and functional properties render LDs excellent candidates for target discovery and design of combined therapeutic strategies. In this review, we summarise the current knowledge identifying LDs and CSCs as main contributors to cancer aggressiveness, metastasis and chemoresistance.
脂质小滴(LDs)曾被视为简单的脂肪储存颗粒,然而新证据表明,它们是动态的功能性细胞器,参与诸如膜生物合成、脂质代谢、细胞信号传导和炎症等关键细胞过程。事实上,LD含量增加是支持癌细胞基本功能所需的脂质代谢重编程最明显的特征之一。LDs与癌症进展和侵袭性所涉及的不同细胞过程相关,如致瘤性、侵袭和转移以及化疗耐药性。有趣的是,所有这些过程都由一类名为癌症干细胞(CSCs)的高侵袭性肿瘤细胞亚群控制,这表明LDs可能是癌症干性的基本要素。鉴于CSCs在化疗耐药性和疾病复发(治疗失败的主要因素)方面的关键作用,设计针对这些细胞的新型治疗方法可能是癌症患者长期生存的唯一机会。从这个意义上说,它们的生物学特性和功能特性使LDs成为靶点发现和联合治疗策略设计的理想候选者。在这篇综述中,我们总结了目前将LDs和CSCs视为癌症侵袭性、转移和化疗耐药性主要促成因素的相关知识。